AI Science Tracker
EN

Ensemble feature selection and tabular data augmentation with generative adversarial networks to enhance cutaneous melanoma identification and interpretability.

Affiliation not stated in the reviewed material · 30 Oct 2024 · medicine

Discovery

Ensemble feature selection and tabular data augmentation with generative adversarial networks to enhance cutaneous melanoma identification and interpretability.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The source compares LASSO, KNN, SVM and decision-tree classifiers using sensitivity, specificity and ROC analysis.

Technology: Ensemble feature selection and GAN-based augmentation improve cutaneous-melanoma identification from tabular/image-derived lesion features.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Ensemble feature selection and GAN-based augmentation improve cutaneous-melanoma identification from tabular/image-derived lesion features.
Limitation / still unknown
The reported classifier comparisons use the study dataset; external validation and clinical screening benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11526724/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.